Professional Nursing Today - Volume 17, Issue 1, 2013
Volume 17, Issue 1, 2013
Author Annelie MeiringSource: Professional Nursing Today 17 (2013)More Less
Nurses delivered a caring service over a 24-hour period at the start of 2013. The media was filled with highlights of babies who were born on New Year, and included beautiful pictures of proud mothers, fathers and their infants. This is unassailable proof of the great service that nurses are rendering. A big thank you to the midwives and nurses who made these events memorable to members of the nation and their families!
Author L. JohnstonSource: Professional Nursing Today 17, pp 4 –5 (2013)More Less
Topical anti-inflammatories and analgesics are ideal for treating localised pain and inflammation affecting soft tissues that are accessible through topical delivery such as the ankle, hip, knee, shoulder or elbow. Topical preparations available in South Africa include gels, lotions, creams, sprays, patches and plasters.
Author B. GreenSource: Professional Nursing Today 17, pp 6 –13 (2013)More Less
Over the last few years, the wound care market has exploded. Numerous technologically advanced dressings have been introduced. In addition, dressings have been designed to treat specific wound aetiologies, e.g. skin substitutes for burns and non-healing recalcitrant ulcers, and protease-modulating dressings to manage the chronic pro-inflammatory wound environment. However, within certain dressing categories there has been a proliferation and duplication of products.
Author J. SouterSource: Professional Nursing Today 17, pp 19 –21 (2013)More Less
Healthcare workers are at an increased risk of contracting certain diseases because of the nature of their occupations. Daily contact with the weakest and most susceptible members of a community predisposes them to being an important potential vector in the transmission of diseases. In this article, recommended vaccines for healthcare workers will be discussed in general, as well those for selected healthcare workers.
Source: Professional Nursing Today 17, pp 24 –27 (2013)More Less
Neonates frequently receive aminoglycosides as empiric therapy for severe infections caused by suspected Gram-negative bacteria. Amikacin is classified as an aminoglycoside. Optimum dosing of aminoglycosides is required because of the inter-individual variability in the pharmacokinetics of aminoglycosides in the neonatal population. Aminoglycosides have the ability to produce nephrotoxicity and ototoxicity. This is a major limitation and concern regarding the use of this class of antibiotics. The ototoxic effects of AG treatment are dose-dependent. Preterm infants are especially susceptible to the ototoxic effects of aminoglycoside drugs, because of the anatomical and functional maturation development of the inner-ear system. Identification of AG ototoxicity is important to minimise long-term damage.
Source: Professional Nursing Today 17, pp 28 –29 (2013)More Less